A Phase 4 interventional study of Metformin in Diabetes Mellitus, Type 2, sponsored by Haydarpasa Numune State Hospital. Completed. Open to participants aged 35 Years to 78 Years. Per ClinicalTrials.gov, last updated 2007-04-20.
Sponsored by Haydarpasa Numune State Hospital · Phase 4 and Interventional
Aim: To investigate the effects of metformin treatment on thyroid hormone metabolism in euthyroid patients with type 2 diabetes mellitus.
10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.
Browse Diabetes Mellitus studies →This is the only study on the registry with Haydarpasa Numune State Hospital as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
No study locations are listed for this record.
This study is completed, as verified in Mar 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.